Literature DB >> 24943205

Use of azathioprine in IBD: modern aspects of an old drug.

Edouard Louis1, Peter Irving2, Laurent Beaugerie3.   

Abstract

Entities:  

Keywords:  AZATHIOPRINE; IBD; LYMPHOMA; THIOPURINE METHYLTRANSFERASE

Mesh：

Substances：

Year:  2014        PMID： 24943205     DOI： 10.1136/gutjnl-2013-306711

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients.

Authors:  Sudeep Dhoj Thapa; Hiba Hadid; Mohammed Usman; Waseem Imam; Ahmad Hassan; Jason Schairer; Syed-Mohammed R Jafri; Nirmal Kaur
Journal:  Dig Dis Sci       Date:  2015-10-28       Impact factor: 3.199

Review 2.  Pharmacologic therapy for inflammatory bowel disease refractory to steroids.

Authors:  M P Martínez-Montiel; B Casis-Herce; G J Gómez-Gómez; A Masedo-González; C Yela-San Bernardino; C Piedracoba; G Castellano-Tortajada
Journal:  Clin Exp Gastroenterol       Date:  2015-08-17

Review 3.  Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.

Authors:  Robin J Dart; Mark A Samaan; Nick Powell; Peter M Irving
Journal:  Clin Exp Gastroenterol       Date:  2017-03-03

4.  Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants.

Authors:  Marianna Lucafò; Gabriele Stocco; Stefano Martelossi; Diego Favretto; Raffaella Franca; Noelia Malusà; Angela Lora; Matteo Bramuzzo; Samuele Naviglio; Erika Cecchin; Giuseppe Toffoli; Alessandro Ventura; Giuliana Decorti
Journal:  Genes (Basel)       Date:  2019-04-04       Impact factor: 4.096

Review 5.  Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?

Authors:  Raphael P Luber; Sailish Honap; Georgina Cunningham; Peter M Irving
Journal:  Front Med (Lausanne)       Date:  2019-11-28

Review 6.  Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α.

Authors:  Jihye Park; Jae Hee Cheon
Journal:  Korean J Intern Med       Date:  2022-07-27       Impact factor: 3.165

7.  Classic drugs in the time of new drugs: real-world, long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease.

Authors:  Ashkan Rezazadeh Ardabili; Steven Jeuring; Zlatan Mujagic; Liekele Oostenbrug; Mariëlle Romberg-Camps; Daisy Jonkers; Adriaan van Bodegraven; Marieke Pierik
Journal:  Aliment Pharmacol Ther       Date:  2022-07-06       Impact factor: 9.524

Review 8.  Optimal management of steroid-dependent ulcerative colitis.

Authors:  Hafiz M Waqas Khan; Faisal Mehmood; Nabeel Khan
Journal:  Clin Exp Gastroenterol       Date:  2015-11-12

9.  Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres.

Authors:  Mark A Samaan; Polychronis Pavlidis; Jonathan Digby-Bell; Emma L Johnston; Angad Dhillon; Ramesh Paramsothy; Abisoye O Akintimehin; Lucy Medcalf; Guy Chung-Faye; Patrick DuBois; Ioannis Koumoutsos; Nick Powell; Simon H C Anderson; Jeremy Sanderson; Bu' Hussain Hayee; Peter M Irving
Journal:  Frontline Gastroenterol       Date:  2017-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.